Oxiracetam – Powder, 50 grams
$47.99
Oxiracetam is a hydroxylated pyrrolidinone derivative within the racetam structural class, distinguished from piracetam by a 4-hydroxy substitution on the pyrrolidinone ring. Research interest centers on its proposed effects on glutamatergic AMPA receptor signalling and cholinergic pathway modulation in neuronal… CAS: 62613-82-5 | Formula: C6H10N2O3 | Content: 50 grams | Research use only | Third-party lab tested.
Buy Oxiracetam – Powder, 50 grams – Swiss Chems USA
Oxiracetam – Powder, 50 grams — Research Overview
Oxiracetam is a hydroxylated pyrrolidinone derivative within the racetam structural class, distinguished from piracetam by a 4-hydroxy substitution on the pyrrolidinone ring. Research interest centers on its proposed effects on glutamatergic AMPA receptor signalling and cholinergic pathway modulation in neuronal models. Research applications include racetam structure-activity relationship studies, AMPA receptor pharmacology, and comparative pyrrolidinone-class compound research.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
Intended use: This material is supplied for laboratory and in-vitro research only. It is not a drug, food, or cosmetic and is not intended for human or animal consumption.
Oxiracetam – Powder, 50 grams Chemical Properties
| Property | Specification |
|---|---|
| Chemical Formula | C6H10N2O3 |
| Synonyms | oxiracetam 62613-82-5, 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide, 4-Hydroxy-2-oxopyrrolidine-N-acetamide, ISF 2522 |
| Molar Mass | 158.16 g/mol |
| CAS Number | 62613-82-5 |
| PubChem CID | 4626 |
| Total Compound Content | 50 grams |
| Shelf Life | 36 months |
Oxiracetam – Powder, 50 grams Research Applications
Oxiracetam is studied within the racetam family for its hydroxyl-substituted pyrrolidinone structure, a modification relative to the parent compound piracetam that is investigated for altered pharmacological profile. Proposed mechanisms under research include modulation of glutamatergic transmission via AMPA-type ionotropic glutamate receptors and influence on high-affinity choline uptake in cholinergic synaptic models, positioning oxiracetam as a tool compound for dissecting overlapping glutamatergic and cholinergic contributions to racetam-class pharmacology. Comparative electrophysiology and receptor-binding studies are used to characterise oxiracetam’s relative potency against other racetam-family compounds at these targets. Independently third-party HPLC-tested; COA available per batch.
Oxiracetam – Powder, 50 grams Frequently Asked Questions
How does oxiracetam’s structural modification relative to piracetam relate to its proposed mechanism of action?
Oxiracetam differs from piracetam by a hydroxyl group at the 4-position of the shared pyrrolidinone ring. This structural modification is studied for its influence on receptor-binding affinity and pharmacokinetic properties relative to the parent compound, within structure-activity relationship research mapping how substitutions on the racetam core scaffold alter target engagement at glutamatergic and cholinergic systems. Comparative binding and functional assays against piracetam and other racetam-family compounds are the standard approach for characterising this relationship.
What electrophysiological methods are used to study oxiracetam’s effects on AMPA receptor signaling?
Patch-clamp electrophysiology in cultured neurons or brain slice preparations is the standard method for characterising compound effects on AMPA receptor-mediated excitatory postsynaptic currents (EPSCs), allowing researchers to quantify changes in current amplitude, kinetics, or desensitization properties following oxiracetam exposure. These functional electrophysiological readouts are typically paired with receptor-binding assays to distinguish direct receptor modulation from indirect effects on presynaptic glutamate release.
What is the research rationale for studying oxiracetam’s combined effects on cholinergic and glutamatergic systems?
Because oxiracetam has been investigated for activity at both glutamatergic AMPA receptors and cholinergic high-affinity choline uptake, it serves as a research tool for studying potential crosstalk or convergent downstream effects between these two neurotransmitter systems on cognitive-relevant cellular endpoints (such as long-term potentiation models). Researchers isolating which pathway drives a given experimental outcome typically use selective antagonists for one system (e.g. an AMPA receptor antagonist) while measuring oxiracetam’s effects on the other, to determine pathway dependence.
Research Use Disclaimer
All product information is provided for educational and laboratory research reference only. Any form of introduction into humans or animals is prohibited. Handle only in licensed research settings in accordance with applicable laws and institutional protocols.
| Weight | 1.7 lbs |
|---|
Related products
Reviews
There are no reviews yet.